Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach

Abstract Maple Syrup Urine Disease (MSUD) disease is a defect in the function of the Branched-chain 2-ketoacid dehydrogenase complex (BCKDH). It is caused by pathogenic biallelic variants in BCKDHA, BCKA decarboxylase, or dihydrolipoamide dehydrogenase. The brain is the major organ involved in MSUD....

Full description

Saved in:
Bibliographic Details
Main Authors: Noushin Rostampour, Setila Dalili, Hossein Moravej, Zhila Afshar, Negar Yazdani, Seyedeh Tahereh Mousavi, Parastoo Rostami, Daniel Zamanfar, Maryam Yahay, Abdolhossein Nikravesh, Zahra Beyzaei, Mohamad Ahangar Davoodi, Atefeh Sedaghat, Tahora Hakemzadeh, Ali Talea
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03533-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544274205736960
author Noushin Rostampour
Setila Dalili
Hossein Moravej
Zhila Afshar
Negar Yazdani
Seyedeh Tahereh Mousavi
Parastoo Rostami
Daniel Zamanfar
Maryam Yahay
Abdolhossein Nikravesh
Zahra Beyzaei
Mohamad Ahangar Davoodi
Atefeh Sedaghat
Tahora Hakemzadeh
Ali Talea
author_facet Noushin Rostampour
Setila Dalili
Hossein Moravej
Zhila Afshar
Negar Yazdani
Seyedeh Tahereh Mousavi
Parastoo Rostami
Daniel Zamanfar
Maryam Yahay
Abdolhossein Nikravesh
Zahra Beyzaei
Mohamad Ahangar Davoodi
Atefeh Sedaghat
Tahora Hakemzadeh
Ali Talea
author_sort Noushin Rostampour
collection DOAJ
description Abstract Maple Syrup Urine Disease (MSUD) disease is a defect in the function of the Branched-chain 2-ketoacid dehydrogenase complex (BCKDH). It is caused by pathogenic biallelic variants in BCKDHA, BCKA decarboxylase, or dihydrolipoamide dehydrogenase. The brain is the major organ involved in MSUD. MSUD happens in about 1 in 86,800 to 185,000 live births. According to some diversity in the management of Iranian patients with MSUD, the development of a national guideline is essential. This guideline is provided through a literature search on articles in PubMed, Scopus, Web of Sciences, Cochrane, and Embase databases from 2001 to 2022 accompanied by a consensus of physicians of different centers in Iran who are experts in the diagnosis and management of this disease. This article considers pathogenesis, epidemiology, clinical manifestations, diagnosis, treatment, and monitoring of MSUD patients with limited recourse.
format Article
id doaj-art-444a59f31c16429695ce2410a49249b9
institution Kabale University
issn 1750-1172
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-444a59f31c16429695ce2410a49249b92025-01-12T12:39:28ZengBMCOrphanet Journal of Rare Diseases1750-11722025-01-0120111110.1186/s13023-025-03533-6Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approachNoushin Rostampour0Setila Dalili1Hossein Moravej2Zhila Afshar3Negar Yazdani4Seyedeh Tahereh Mousavi5Parastoo Rostami6Daniel Zamanfar7Maryam Yahay8Abdolhossein Nikravesh9Zahra Beyzaei10Mohamad Ahangar Davoodi11Atefeh Sedaghat12Tahora Hakemzadeh13Ali Talea14Liver Disease Research Center, Isfahan University of Medical SciencesPediatric Diseases Research Center, Guilan University of Medical SciencesNeonatal Research Center, Shiraz University of Medical SciencesDepartment of Pediatrics Endocrinology, Shiraz University of Medical SciencesCommunity Based Psychiatric Care Research Center, School of Nursing and Midwifery, Shiraz University of Medical SciencesAssisstant Professor of Pediatrics Endocrinology, School of Medicine, Bushehr University of Medical SciencesDivision of Endocrinology and Metabolism, Department of Pediatrics, Children’s Medical Center, Tehran University of Medical SciencesDiabetic Research Center, Mazandaran University of Medical SciencesDepartment of Clinical Nutrition Food Sciences & Technology, School of Nutrition & Food Sciences, Isfahan University of Medical SciencesDepartment of Pediatric Endocrinology & Metabolism, Bushehr University of Medical SciencesShiraz Transplant Research Center (STRC), Shiraz University of Medical SciencesDepartment of Pediatric Endocrinology & Metabolism, Arak University of Medical Sciences, Clinical Research Development Center of Amirkabir HospitalDepartment of Pediatrics Endocrinology, Shiraz University of Medical SciencesPediatric Diseases Research Center, Guilan University of Medical SciencesPediatric Endocrinologist, Metabolic Disorders Research Center, Molecular-cellular Endocrinology & Metabolism Research Institute, Tehran University of medical SciencesAbstract Maple Syrup Urine Disease (MSUD) disease is a defect in the function of the Branched-chain 2-ketoacid dehydrogenase complex (BCKDH). It is caused by pathogenic biallelic variants in BCKDHA, BCKA decarboxylase, or dihydrolipoamide dehydrogenase. The brain is the major organ involved in MSUD. MSUD happens in about 1 in 86,800 to 185,000 live births. According to some diversity in the management of Iranian patients with MSUD, the development of a national guideline is essential. This guideline is provided through a literature search on articles in PubMed, Scopus, Web of Sciences, Cochrane, and Embase databases from 2001 to 2022 accompanied by a consensus of physicians of different centers in Iran who are experts in the diagnosis and management of this disease. This article considers pathogenesis, epidemiology, clinical manifestations, diagnosis, treatment, and monitoring of MSUD patients with limited recourse.https://doi.org/10.1186/s13023-025-03533-6Maple syrup urine diseaseInherited metabolic disorderBCKDHABCKDHB
spellingShingle Noushin Rostampour
Setila Dalili
Hossein Moravej
Zhila Afshar
Negar Yazdani
Seyedeh Tahereh Mousavi
Parastoo Rostami
Daniel Zamanfar
Maryam Yahay
Abdolhossein Nikravesh
Zahra Beyzaei
Mohamad Ahangar Davoodi
Atefeh Sedaghat
Tahora Hakemzadeh
Ali Talea
Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
Orphanet Journal of Rare Diseases
Maple syrup urine disease
Inherited metabolic disorder
BCKDHA
BCKDHB
title Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
title_full Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
title_fullStr Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
title_full_unstemmed Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
title_short Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach
title_sort comprehensive iranian guidelines for the diagnosis and management of maple syrup urine disease an evidence and consensus based approach
topic Maple syrup urine disease
Inherited metabolic disorder
BCKDHA
BCKDHB
url https://doi.org/10.1186/s13023-025-03533-6
work_keys_str_mv AT noushinrostampour comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT setiladalili comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT hosseinmoravej comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT zhilaafshar comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT negaryazdani comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT seyedehtaherehmousavi comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT parastoorostami comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT danielzamanfar comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT maryamyahay comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT abdolhosseinnikravesh comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT zahrabeyzaei comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT mohamadahangardavoodi comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT atefehsedaghat comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT tahorahakemzadeh comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach
AT alitalea comprehensiveiranianguidelinesforthediagnosisandmanagementofmaplesyrupurinediseaseanevidenceandconsensusbasedapproach